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The molecular mechanisms that regulate synapse formation have been well documented. However, little is known about the factors that
modulate synaptic stability. Synapse loss is an early and invariant feature of neurodegenerative diseases including Alzheimer’s (AD)
and Parkinson’s disease. Notably, in AD the extent of synapse loss correlates with the severity of the disease. Hence, understanding the
molecular mechanisms that underlie synaptic maintenance is crucial to reveal potential targets that will allow the development of ther-
apies to protect synapses. Wnts play a central role in the formation and function of neuronal circuits. Moreover, Wnt signaling compo-
nents are expressed in the adult brain suggesting their role in synaptic maintenance in the adult. Indeed, blockade of Wnts with the Wnt
antagonist Dickkopf-1 (Dkk1) causes synapse disassembly in mature hippocampal cells. Dkk1 is elevated in brain biopsies from AD
patients and animal models. Consistent with these findings, Amyloid-b (Ab) oligomers induce the rapid expression of Dkk1.
Importantly, Dkk1 neutralizing antibodies protect synapses against Ab toxicity, indicating that Dkk1 is required for Ab-mediated
synapse loss. In this review, we discuss the role of Wnt signaling in synapse maintenance in the adult brain, particularly in relation
to synaptic loss in neurodegenerative diseases.
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Introduction
Appropriate formation, maintenance, and elimination of synap-
ses are crucial to guarantee the formation of a functional nervous
system. In the last decade, great advances have been made in
understanding the molecular mechanisms that regulate the forma-
tion and function of synapses. However, the factors that modulate
synaptic maintenance in the adult brain are less understood.
Several neurodegenerative diseases such as Alzheimer’s (AD)
and Parkinson’s disease exhibit early loss of synapses, which cor-
relates with the manifestation of cognitive and/or motor symptoms
and subsequent neuronal degeneration. Therefore, protecting
synapses early in the disease could provide an effective therapeut-
ic approach for the treatment of these diseases.
Wnts are a large family of secreted glycoproteins that promote
synaptogenesis and regulate synaptic function in both vertebrates
and invertebrates (Inestrosa and Arenas, 2010; Shen and Cowan,
2010; Budnik and Salinas, 2011; Salinas, 2012). Binding of Wnts
to Frizzled (Fz) receptors can activate different pathways. In the ca-
nonical orb-catenin pathway, Wnts act through Fz receptors and the
co-receptor low density lipoprotein receptor-related protein 5/6
(LRP5 or LRP6), requiring the scaffold protein Dishevelled (Dvl;
Figure 1). Activation of this pathway results in the inhibition of the
serine/threonine kinase glycogen synthase kinase-3 (Gsk3),
which in the absence of Wnts phosphorylates b-catenin increasing
its instability. In the presence of Wnts, b-catenin is stabilized and
translocates to the nucleus where it activates the transcription of
target genes (Clevers and Nusse, 2012). A divergent canonical
pathway, independent of transcription, requires the plus-end micro-
tubule binding protein Adenomatous polyposis coli to regulate
axonal remodeling (Ciani et al., 2004; Purro et al., 2008), a
process that precedes presynaptic assembly. The non-canonical
pathways include the planar cell polarity pathway, with the activa-
tion of Rho GTPases and Jun N-terminal kinase (JNK), and the
calcium pathway, where an increase in intracellular calcium acti-
vates the calcium/calmodulin-dependent protein kinase II
(CaMKII) and protein kinase C. Wnts recruit synaptic proteins to
the presynaptic terminals through the activation of the canonical
pathway (Hall et al., 2000; Packard et al., 2002; Ahmad-Annuar
et al., 2006; Davis et al., 2008) and also recruit postsynaptic pro-
teins by either the canonical or non-canonical pathway (Farias
et al., 2009; Ciani et al., 2011). Therefore, Wnts can act through dif-
ferent signaling cascades to function as synaptogenic molecules.
The role of Wnts in synapse formation, growth, and plasticity has
been well documented both in the central and peripheral nervous
systems (Inestrosa and Arenas, 2010; Budnik and Salinas, 2011;
# The Author (2014). Published by Oxford University Press on behalf of Journal of
Molecular Cell Biology, IBCB, SIBS, CAS.
This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits
unrestricted reuse, distribution, and reproduction in any medium, provided the
original work is properly cited.
doi:10.1093/jmcb/mjt049 Journal of Molecular Cell Biology (2014), 6, 75–80 | 75
 at U







Koles and Budnik, 2012; Salinas, 2012). However, Wnts, their
receptors, and many of the components of the signaling pathway
are also expressed in the adult brain, suggesting that they might
have a role in synaptic stability. Here we review recent studies
that strongly suggest a role of Wnt signaling in the maintenance
of synapses in the adult brain and indicate that dysfunction of
Wnt signaling may contribute to the loss of synapses in AD. We
will also discuss how modulation of Wnt signaling could be used
as a therapeutic strategy for the treatment of neurodegenerative
diseases beyond AD.
Wnt signaling on synaptic formation and function
A variety of evidence demonstrates a role for Wnts in the forma-
tion and growth of synapses. In the cerebellum, Wnt7a is required
for the formation of synapses between granule cell dendrites and
mossy fiber axons by promoting axonal remodeling and the recruit-
ment of presynaptic proteins (Hall et al., 2000). Prior to the forma-
tion of synaptic boutons, Wnts induce extensive remodeling of
axons that results from a decrease in axon extension and the con-
comitant increase of the size of their growth cones (Hall et al.,2000;
Purro et al., 2008). Gain and loss of function studies demonstrate
that Wnt7a and Dvl1 are crucial for the recruitment of presynaptic
proteins to future synaptic boutons, therefore, increasing the
number and size of synaptic vesicle recycling sites (Ahmad-
Annuar et al., 2006). Consistent with a role of Wnts in synapse for-
mation, the Wnt7a/Dvl1 double mutant mice exhibit defects in the
frequency, but not amplitude, of miniature excitatory postsynaptic
currents (Ahmad-Annuar et al.,2006). Further studies demonstrate
that downstream of Dvl1 lays Gsk3, as inhibition of this kinase
mimics the effect of Wnt7a (Hall et al., 2000). In cultured
neurons, Wnt5a also induces the recruitment of presynaptic com-
ponents, but the mechanism remains elusive (Paganoni et al.,
2010; Varela-Nallar et al., 2012). Together, these findings demon-
strate that several Wnts can regulate the formation of synapses by
promoting the assembly of the presynaptic terminal.
Wnts can signal through many receptors to induce synapse
formation. For example, both Wnt3a via Fz1 and Wnt5a via Ror
tyrosine receptors increase the number of presynaptic sites on hip-
pocampal cultures (Varela-Nallar et al., 2009; Paganoni et al.,
2010). The receptor Fz5 is required for Wnt7a to stimulate syn-
aptogenesis in the hippocampus, as shRNA knockdown of Fz5
blocks Wnt7a function (Sahores et al., 2010). Apart from these
findings, little is known about the receptors needed for other
synaptogenic Wnts and their different targets. Interestingly, en-
dogenous Wnts are required for surface localization of Fz5 and
for the formation of synaptic sites elicited by neuronal activity
(Sahores et al., 2010). These findings revealed an important role
for Wnts in activity-mediated changes at the synapse. However,
further studies are required to elucidate the mechanisms that
control the trafficking of Wnt receptors and their consequences
on synapse formation and growth.
Wnts also promote postsynaptic assembly with the added com-
plexity that different Wnts might modulate either side of the
synapse through different pathways. In hippocampal neurons,
Wnt7a signals bidirectionally to the synapse. Wnt7a increases the
number and function of excitatory synapses by activating canonical
Wnt signaling at the presynapse (Cerpa et al., 2008; Ciani et al.,
2011). Signaling directly to the postsynaptic side, Wnt7a induces
the localization and activation of CaMKII at spines, increasing syn-
aptic strength. Indeed, Wnt7a-Dvl1-deficient mice exhibit defects
in spine morphogenesis and excitatory synaptic transmission in
the hippocampus (Ciani et al., 2011). Another complexity lies in
the fact that different Wnts modulate distinct types of synapses.
Wnt7a specifically regulates the formation of excitatory synapses
without changing the number of inhibitory ones (Ciani et al.,
2011), while Wnt5a promotes synaptic assembly on both excitatory
and inhibitory hippocampal neurons (Cuitino et al., 2010;
Varela-Nallar et al., 2010). In contrast to Wnt7a, Wnt5a induces
postsynaptic assembly and increases the levels of g-aminobutyric
acid type a (GABAA) receptors by activating non-canonical Wnt sig-
naling in hippocampal neurons (Farias et al., 2009; Cuitino et al.,
2010; Varela-Nallar et al., 2010). Wnt5a increases the amplitude
but not the frequency of miniature inhibitory postsynaptic currents,
suggesting that Wnt5a increases and maintains GABA receptors on
the postsynaptic membrane without affecting GABA release from
the presynaptic side (Cuitino et al., 2010). Interestingly, Wnt5a acti-
vates different Wnt pathways at the postsynapse. The recruitment of
postsynaptic proteins is achieved by activation of JNK, whereas the
modulation of GABA receptors requires CaMKII (Farias et al., 2009;
Cuitino et al.,2010; Varela-Nallaret al.,2010). Invivodata on Wnt5a
function and in vitrodetailed studies are needed to clarify the mech-
anism and targets on each side of the synapse. Future experiments
will elucidate the mechanisms by which different Wnts regulate the
formation of different types of synapses, and whether different
mechanisms govern the assemblyof the pre- and postsynaptic sites.
Figure 1 Canonical Wnt signaling. Left panel: binding of Wnts to
Frizzled receptors and co-receptor LRP5/6 induces association of
Axin with phosphorylated LRP6 and recruitment of Dvl and CK1 in a
complex that binds and inhibits Gsk3b. Blockade of Gsk3b results in
the accumulation of b-catenin in the cytoplasm, which translocates
to the nucleus to induce gene expression. Right panel: Dkk1 is a
secreted Wnt antagonist that binds to the LRP5/6. Hence, Wnts can
no longer signal through the canonical pathway and inhibit Gsk3b,
which in turn phosphorylates b-catenin, targeting it for degradation
by the proteasome.
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Modulation of synaptic maintenance by Wnt signaling
The expression of Wnts and signaling components in the adult
brain suggests their potential role in synaptic maintenance
(Shimogori et al., 2004; Gogolla et al., 2009; Sahores et al.,
2010; Seib et al., 2013). Indeed, experiments using a secreted
Wnt antagonist, Dickkopf-1 (Dkk1), demonstrate a role for Wnts
in synaptic maintenance in mature hippocampal neurons. Dkk1
binds to LRP6 inhibiting Wnt canonical signaling (Niehrs, 2006).
In mature neurons, short-term exposure to Dkk1 induces a de-
crease in the number and size of synaptic protein clusters,
decreases the number of functional synaptic vesicle recycling
sites, and promotes dispersion of pre- and postsynaptic proteins in-
dicating loss of synapses. This effect was achieved by a redistribu-
tion of the synaptic proteins, as the total level of proteins remained
unaffected (Purro et al., 2012). Ultrastructural studies showed that
Dkk1 decreases the length of the active zone and the postsynaptic
density area of remaining synapses, consistent with the view that
remaining synapses are smaller or have shrunk. Indeed, time-lapse
recordings of VAMP-mRFP-labeled stable synaptic sites indicate
that Wnt blockade by Dkk1 rapidly disassembles synapses, de-
creasing the number, size, and intensity of synaptic puncta
(Purro et al., 2012). Given that the effect of Dkk1 can be reverted
by Wnts or inhibition of Gsk3 (unpublished data), these findings
strongly suggest that endogenous Wnts expressed by mature
neurons are crucial for the maintenance of synaptic connections
in the adult brain.
AD and Wnt signaling
It is estimated that 35 million people suffer dementia worldwide
and the number of cases is expected to triple by 2050 (Prince and
Jackson, 2009) having a significant economical and social impact.
AD is the most common form of dementia with increasing costs
on health systems and society. However, existing treatments are
only palliatives and no cure for this disease has yet been found.
Memory loss, changes in personality and behavior, and a gradual
loss of mental abilities are the most characteristic symptoms of
the disease (Prince and Jackson, 2009).
In the brain, tangles and plaques, the hallmarks of AD, accumu-
late and cause neurodegeneration (Selkoe, 2011). Neurofibrillary
tangles (NFTs) are aggregates of hyperphosphorylated Tau, a
microtubule binding protein, while plaques are mainly deposits
of amyloid-b peptides (Ab), the product from the shedding of
amyloid-b precursor protein (APP) (Selkoe et al., 1996). Although
plaques and NFTs are toxic, synapses are lost before plaque depos-
ition and NFTs are significant in the brain. It is widely accepted that
soluble Ab aggregates cause synapse dysfunction and loss, prob-
ably linked to the cognitive impairments characteristic of AD
(Ferreira and Klein, 2011). During the disease, there is a significant
loss of synapses, which correlates best with the cognitive decline
(Terry et al., 1991; Palop and Mucke, 2010). Evidence from
in vitro and in vivo studies indicates that soluble Ab aggregates
like dimers, trimers, and different sized oligomers are the synapto-
toxic species (Walsh and Selkoe, 2007; Ferreira and Klein, 2011;
Larson and Lesne, 2012). However, the mechanisms by which Ab
induces synaptic damage are poorly understood.
The toxic effects of Ab on synapses could be due to its impact on
the expression or function of synaptic maintenance factors and
suggest that protection of synapses early in the disease could
ameliorate the impact of Ab toxicity. Therefore, understanding
the molecular mechanisms that regulate synaptic maintenance is
crucial for developing approaches to block the effect of Ab and
therefore protect or even restore neuronal connectivity.
Several studies link a deficiency in canonical Wnt signaling with
AD (see review in (Inestrosa et al., 2012)). Dkk3, highly related to
Dkk1, is elevated in plasma and cerebrum spinal fluid from AD
patients, supporting that deregulation of Wnt signaling takes
place during AD (Zenzmaier et al., 2009). Further evidence comes
from the finding that Ab binds to Fz5, although the significance
of this finding remains to be explored (Magdesian et al., 2008).
The Wnt antagonist Dkk1 is elevated in post-mortem brain
samples from AD patients and brains from transgenic AD animal
models (Caricasole et al., 2004; Rosi et al., 2010), suggesting
that dysfunction of Wnt pathway could contribute to the loss of
synapses in AD. Importantly, genome-wide association studies
showed a link between a variant of the LRP6 receptor with late
onset of AD. This identified LRP6 variant exhibits lower activation
of gene transcription upon addition of Wnt3a in heterologous
cells (De Ferrari et al., 2007). Together, these studies strongly
suggest that dysfunction of the canonical Wnt pathway is asso-
ciated with AD and raise the interesting possibility that Dkk1 med-
iates the loss of synapses characteristic of AD.
How does Ab affect Wnt signaling at the synapse? Studies on
mouse brain slices have demonstrated that short-term exposure
to Ab induces the loss of synapses concomitantly with increased
expression of Dkk1 (Purro et al., 2012) (Figure 2). Importantly, a
neutralizing antibody against Dkk1 protected synapses from the
deleterious effect of Ab. As mentioned above, Wnt blockade by
Dkk1 quickly disassembles synaptic sites resulting in the loss of
synapses. We propose that the effect of Dkk1 is due to blockade
of endogenous Wnt ligands that are crucial for synapse mainten-
ance. Several results support this conclusion. First, several Wnt
Figure 2 Dkk1 is crucial for synaptic disassembly and loss induced by
Ab. Left panel: Wnts by binding to Frizzled and LRP5/6 regulate the
maintenance of synapses at the pre- and postsynaptic site in the
adult brain. Right panel: Ab induces Dkk1 expression (dotted
arrows). Dkk1 blocks canonical Wnt signaling, activating a dispersal
mechanism of synaptic components leading to decrease in the size of
the synapse and disassembly.
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factors, their receptors, and components of the Wnt signaling
pathway are expressed in the adult brain. Second, the synaptic
effect of Dkk1 can be blocked by Wnt ligands. Third, activation of
the canonical Wnt pathway by inhibiting Gsk3 blocks the effect of
Dkk1 (unpublished data). Together, these results demonstrate
that endogenous Wnts contribute to synaptic stability and this
crucial function is disrupted by the accumulation of Ab, which
results in the elevation of Dkk1, otherwise not present in the
healthy brain. Dkk1 in turn induces the loss of synapses. These
findings strongly suggest a link between dysfunction of Wnt signal-
ing and Ab-mediated synaptotoxicity.
Dysfunction of Wnt signaling, cognitive decline and synaptic
disassembly
Loss of synapses, spines, and dendrites precedes neuronal de-
generation and is thought to underlie the symptoms in several neu-
rodegenerative diseases (Lin et al.,2009; Shankar and Walsh,2009;
Milnerwood and Raymond, 2010; Moreno and Mallucci, 2010). In
AD, there is a strong correlation between synaptic loss and cognitive
decline, and this occurs independently of neuronal death (Naslund
et al., 2000; Shankar and Walsh, 2009). A recent study showed that
Dkk1expression increases withage in the mouse hippocampus con-
comitantly with a decline in spatial working memory (Seib et al.,
2013). Importantly, loss of Dkk1 expression using ShRNA in the
hippocampus of aged mice enhances spatial working memory and
memory consolidation (Seib et al., 2013). These data indicate that
dysfunction of Wnt signaling causes cognitive impairment.
Interestingly, Dkk1 and the secreted frizzled-related protein 3
(Sfrp3), both antagonists of Wnts, affect the stem cell niche in the
adult dentate gyrus (Jang et al., 2013; Seib et al., 2013). However,
the effect of these Wnt inhibitors on synapses and connectivity
remains to be studied. Given the effect of Dkk1 on the rapid disas-
sembly of synapses (Purro et al., 2012), we would predict that
knockdown of Dkk1 could induce changes in synaptic connectivity
by directly affecting existing neurons and synapses. At any rate,
these findings demonstrate the importance of endogenous Wnt sig-
naling in hippocampal-mediated behavior. They also suggest that
Wnt dysfunction could contribute not only to age-related cognitive
decline but also to render synapses more vulnerable to toxic factors
like Ab oligomers (Figure 3).
The expression of Wnt proteins changes with age. For example,
Wnt7a/b levels increase between 6 and 12 months of age in
mouse hippocampus, and this is followed by a decrease in the
number of synapses (Gogolla et al., 2009). This raises the interest-
ing possibility that Wnt-dependent synaptic stability decreases
with age. In a recent study, it was shown that prolonged exposure
to enriched environment (EE) enlarges dendritic spines, enhances
hippocampal plasticity, and alleviates the synaptotoxicity of Aboli-
gomers from AD brain patients (Li et al., 2013). This highlights the
importance of synaptic stability and function to overcome the toxic
effects of Ab. It is well documented that EE produces a robust in-
crease in the number of excitatory synapses in the CNS (Moser
et al., 1997; Gogolla et al., 2009; Baroncelli et al., 2010; Bednarek
and Caroni, 2011) and interestingly, EE also increases the level of
Wnt7a/b in CA3 pyramidal neurons in the hippocampus (Gogolla
et al., 2009). Indeed, blockade of Wnt signaling with Sfrp1 sup-
presses the effect of EE on synaptic remodeling (Gogolla et al.,
2009). As the levels of Wnts and the number of synapses decrease
in aged mice, we propose that remaining synapses might become
more vulnerable to Ab toxicity and therefore to disassembly in
the aging brain. In contrast, increasing the number of synapses,
by exposure to sensory, motor, or social stimuli might be protective
during the early stages of the disease. Interestingly, restoration of
Wnt signaling in aged individuals may provide an alternative
therapy to prevent the disassembly of synapses and concomitant
symptoms of AD.
Ab is known to increase the expression of the Wnt antagonist
Dkk1 (Caricasole et al., 2004; Killick et al., 2014; Purro et al.,
2012), whereas blockade of Dkk1 suppresses Ab synaptotoxicity
(Purro et al., 2012). However, the mechanism by which Ab and
Dkk1 induce synaptic disassembly still remains elusive. Recently,
it was shown that Ab induces intracellular accumulation of the
Figure 3 Potential stages in the synaptic pathogenesis in AD. During
the disease, accumulation of Ab oligomers induces the expression of
the Wnt antagonist Dkk1. Dkk1 induces synaptic disassembly and inhi-
bits neurogenesis, therefore resulting in a decrease in global synaptic
connectivity in the brain. Decline in synaptic connectivity would con-
tribute to impairment in memory, suggesting that Ab/Dkk1-mediated
loss of synapses underlies the cognitive decline observed at early
stages of AD.
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survival factor clusterin and indeed, knockdown of clusterin in
primary neurons reduced Ab toxicity and the upregulation of
Dkk1 (Killick et al., 2014), suggesting that Dkk1-mediated Ab
neurotoxicity occurs via clusterin. Interestingly, clusterin accumu-
lation would induce activation of p53 pathway and certainly, inhib-
ition of p53 blocks Ab induction of Dkk1 (Killick et al., 2014). These
studies provide for the first time a mechanism that links dysfunc-
tional Wnt signaling with Ab toxicity. It would be crucial to establish
whether in vivo p53-mediated increase of Dkk1 also contributes to
synaptic disassembly induced by Ab.
Concluding remarks
Wnt signaling is critical for the formation of neuronal circuits by
modulating axon pathfinding, dendritic development, and synaptic
assembly and function. Furthermore, Wnts mediate synaptic struc-
tural changes induced by neuronal activity or experience. The role
of Wnt signaling in the regulation of synaptic maintenance in the
adult brain is now beginning to emerge. Wnt signaling molecules
are present in the adult brain. Indeed, certain Wnts change their ex-
pression throughout life and these changes are accompanied by
changes in the number of synapses. Whether the decrease in synap-
ses is indeed dueto the lower levelsof Wntsneedstobe corroborated.
Future studies should provide further understanding on the contribu-
tion of Wnts, their receptors, and downstream signaling components
during aging. Importantly, invivostudies will provide pivotal evidence
for the contribution of Wnts to synaptic maintenance during aging.
In neurodegenerative diseases like AD, the loss of synapses that
occurs at early stages correlates with cognitive decline, and these
arise prior to the onset of neuronal degeneration. It is now clear
that Wnt signaling plays a role in the onset of neurodegenerative
diseases like AD. Certainly, dysfunction of Wnt pathway mediates
Ab-induced synaptic disassembly and might contribute to memory
impairment and cognitive decline. Different components of the
Wnt pathway like Dkk1, the Wnt antagonist Dkk3, and the
co-receptor LRP6 are now linked to AD. Importantly, Dkk1 mediates
the effect of Ab on synaptic disassembly. Future studies will shed
new light into the mechanisms underlying Wnt–Ab-mediated synap-
tic disassembly and whether dysfunction in Wnt signaling also con-
tributesto the loss ofsynapses inother neurodegenerative diseases.
Wnts’ contribution to synaptic maintenance in the adult raises
the interesting possibility that new therapies may arise by using
Wnts or small molecules that mimic Wnt signaling to protect synap-
ses. By protecting synapses at early stages of neurodegenerative
diseases, these new therapies may ameliorate the symptoms and
potentially delay the onset of neuronal degeneration.
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